Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
0.967
+0.006 (0.57%)
At close: Nov 21, 2024, 4:00 PM
0.960
-0.007 (-0.73%)
After-hours: Nov 21, 2024, 6:32 PM EST
Prelude Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -131.52 | -121.83 | -115.44 | -111.69 | -56.93 | -27.57 | |
| Depreciation & Amortization | 1.61 | 1.17 | 1.32 | 0.92 | 0.54 | 0.38 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.01 | 0.01 | |
| Loss (Gain) From Sale of Investments | -4.76 | -3.47 | 2.59 | 1.36 | - | - | |
| Stock-Based Compensation | 23.48 | 25.62 | 25.14 | 20.93 | 5.58 | 0.85 | |
| Other Operating Activities | 1.81 | 1.94 | 1.72 | 1.33 | - | - | |
| Change in Accounts Payable | 1.03 | -2.27 | -0.35 | 3.9 | 1.16 | 0.55 | |
| Change in Other Net Operating Assets | 2.62 | -8.21 | 1.28 | -0.28 | 3.46 | 0.12 | |
| Operating Cash Flow | -105.72 | -107.06 | -83.73 | -83.53 | -46.18 | -25.67 | |
| Capital Expenditures | -1.84 | -3.51 | -3.02 | -2.32 | -0.62 | -0.78 | |
| Investment in Securities | 77.65 | -31.13 | 84.71 | -261.48 | - | - | |
| Investing Cash Flow | 75.81 | -34.65 | 81.69 | -263.8 | -0.62 | -0.78 | |
| Long-Term Debt Repaid | - | - | - | - | -0.26 | -0.12 | |
| Net Debt Issued (Repaid) | -0.24 | - | - | - | -0.26 | -0.12 | |
| Issuance of Common Stock | 25.55 | 136.41 | 0.82 | 165.2 | 166.73 | 0.01 | |
| Repurchase of Common Stock | -0.05 | -0.02 | - | - | - | - | |
| Other Financing Activities | -0.11 | - | - | -0.3 | -0.01 | - | |
| Financing Cash Flow | 25.15 | 136.4 | 0.82 | 164.9 | 246.23 | 29.73 | |
| Net Cash Flow | -4.76 | -5.31 | -1.22 | -182.44 | 199.43 | 3.28 | |
| Free Cash Flow | -107.56 | -110.58 | -86.75 | -85.85 | -46.8 | -26.45 | |
| Free Cash Flow Per Share | -1.45 | -1.83 | -1.83 | -1.86 | -3.75 | -15.85 | |
| Levered Free Cash Flow | -61.55 | -58.93 | -50.12 | -46.86 | -25.58 | -16.34 | |
| Unlevered Free Cash Flow | -61.55 | -58.93 | -50.12 | -46.86 | -25.58 | -16.34 | |
| Change in Net Working Capital | -4.73 | -0.48 | -3.64 | -4.7 | -5.64 | -0.79 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.